CLINICAL_TRIALS
trial_result
· 2013-06-06
Clinical Trial Update: Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors [Phase 1]
Summary
A Phase 1 clinical trial of interferon gamma-1b in patients with recurrent or metastatic melanoma and other solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED